232 related articles for article (PubMed ID: 28491865)
1. The Role of the Central Nervous System Microenvironment in Pediatric Acute Lymphoblastic Leukemia.
Gossai NP; Gordon PM
Front Pediatr; 2017; 5():90. PubMed ID: 28491865
[TBL] [Abstract][Full Text] [Related]
2. Disrupting the leukemia niche in the central nervous system attenuates leukemia chemoresistance.
Jonart LM; Ebadi M; Basile P; Johnson K; Makori J; Gordon PM
Haematologica; 2020 Aug; 105(8):2130-2140. PubMed ID: 31624109
[TBL] [Abstract][Full Text] [Related]
3. Integrin-Mediated Adhesion and Chemoresistance of Acute Lymphoblastic Leukemia Cells Residing in the Bone Marrow or the Central Nervous System.
Scharff BFSS; Modvig S; Marquart HV; Christensen C
Front Oncol; 2020; 10():775. PubMed ID: 32528884
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
5. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
[TBL] [Abstract][Full Text] [Related]
6. The CNS microenvironment promotes leukemia cell survival by disrupting tumor suppression and cell cycle regulation in pediatric T-cell acute lymphoblastic leukemia.
Enlund S; Sinha I; Neofytou C; Amor AR; Papadakis K; Nilsson A; Jiang Q; Hermanson O; Holm F
Exp Cell Res; 2024 Apr; 437(2):114015. PubMed ID: 38561062
[TBL] [Abstract][Full Text] [Related]
7. Comparison of maintenance treatment regimens for first central nervous system relapse in children with acute lymphocytic leukemia. A Pediatric Oncology Group study.
Land VJ; Thomas PR; Boyett JM; Glicksman AS; Culbert S; Castleberry RP; Berry DH; Vats T; Humphrey GB
Cancer; 1985 Jul; 56(1):81-7. PubMed ID: 3859359
[TBL] [Abstract][Full Text] [Related]
8. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse.
Unal S; Yetgin S; Cetin M; Gümrük F; Arslan D; Ozyürek E; Tuncer M; Topçu M
Pediatr Hematol Oncol; 2004; 21(3):279-89. PubMed ID: 15202168
[TBL] [Abstract][Full Text] [Related]
9. The bone marrow microenvironment as a mediator of chemoresistance in acute lymphoblastic leukemia.
Meyer LK; Hermiston ML
Cancer Drug Resist; 2019; 2(4):1164-1177. PubMed ID: 35582273
[TBL] [Abstract][Full Text] [Related]
10. Natural history of central nervous system acute leukemia in adults.
Stewart DJ; Keating MJ; McCredie KB; Smith TL; Youness E; Murphy SG; Bodey GP; Freireich EJ
Cancer; 1981 Jan; 47(1):184-96. PubMed ID: 7459807
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues.
Gaudichon J; Jakobczyk H; Debaize L; Cousin E; Galibert MD; Troadec MB; Gandemer V
Blood Rev; 2019 Jul; 36():40-56. PubMed ID: 31010660
[TBL] [Abstract][Full Text] [Related]
12. New attempts for central nervous infiltration of pediatric acute lymphoblastic leukemia.
Zhou F; Wen Y; Jin R; Chen H
Cancer Metastasis Rev; 2019 Dec; 38(4):657-671. PubMed ID: 31820149
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Reprogramming and Cell Adhesion in Acute Leukemia Adaptation to the CNS Niche.
Sharma ND; Keewan E; Matlawska-Wasowska K
Front Cell Dev Biol; 2021; 9():767510. PubMed ID: 34957100
[TBL] [Abstract][Full Text] [Related]
14. The effect of central nervous system involvement and irradiation in childhood acute lymphoblastic leukemia: Lessons from the NOPHO ALL-92 and ALL-2000 protocols.
Taskinen M; Oskarsson T; Levinsen M; Bottai M; Hellebostad M; Jonsson OG; Lähteenmäki P; Schmiegelow K; Heyman M
Pediatr Blood Cancer; 2017 Feb; 64(2):242-249. PubMed ID: 27748030
[TBL] [Abstract][Full Text] [Related]
15. CD99 antibody disrupts T-cell acute lymphoblastic leukemia adhesion to meningeal cells and attenuates chemoresistance.
Ebadi M; Jonart LM; Ostergaard J; Gordon PM
Sci Rep; 2021 Dec; 11(1):24374. PubMed ID: 34934147
[TBL] [Abstract][Full Text] [Related]
16. Outcome after relapse in childhood acute lymphoblastic leukemia.
Yumura-Yagi K; Hara J; Horibe K; Tawa A; Komada Y; Oda M; Nishimura S; Yoshida M; Kudo T; Ueda K;
Int J Hematol; 2002 Jul; 76(1):61-8. PubMed ID: 12138898
[TBL] [Abstract][Full Text] [Related]
17. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of central nervous system relapse of pediatric acute lymphoblastic leukemia: Impact of routine cytological CSF analysis at the time of intrathecal chemotherapy.
Gassas A; Krueger J; Alvi S; Sung L; Hitzler J; Lieberman L
Pediatr Blood Cancer; 2014 Dec; 61(12):2215-7. PubMed ID: 25212396
[TBL] [Abstract][Full Text] [Related]
19. Timing and Utility of Relapse Surveillance after Allogeneic Hematopoietic Cell Transplantation in Children with Leukemia.
Levinson A; Arnold S; Jin Z; Bhatia M; George D; Garvin JH; Satwani P
Biol Blood Marrow Transplant; 2017 Apr; 23(4):696-700. PubMed ID: 28063963
[TBL] [Abstract][Full Text] [Related]
20. Relapsed Childhood Acute Lymphoblastic Leukemia: A Single-Institution Experience.
Tuong PN; Kiem Hao T; Kim Hoa NT
Cureus; 2020 Jul; 12(7):e9238. PubMed ID: 32821584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
